(MIRM) – Globe Newswire
-
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
-
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer
-
Travere Therapeutics Completes Sale of Bile Acid Product Portfolio to Mirum Pharmaceuticals
-
Travere Therapeutics Enters Agreement to Sell its Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases to Mirum Pharmaceuticals
Back to MIRM Stock Lookup
